Funding Opportunities
PAR-23-258: Analytical and Clinical Validation of Biomarkers for Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)
PAR-23-274: Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel Therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
RFA-AG-24-028: Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD (R01 Clinical Trial Not Allowed)
RFA-AG-24-029: Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD (R21 Clinical Trial Not Allowed)
RFA-AG-24-041: Neural and Non-Neural Mechanisms Underlying Gait as a Preclinical Marker for Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (R01 Clinical Trial Optional)
RFA-AG-24-046: Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed)
RFA-AG-24-027: Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed)
RFA-AG-24-030: Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional)
RFA-AG-24-031: Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care (R01 Clinical Trial Optional)
RFA-AG-24-042: NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional)
RFA-AG-24-043: NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional)
RFA-AG-24-045: Elucidating Variability of Physiologic and Functional Responses to Exercise Training in Older Adults (R01 Clinical Trial Required)
Notices
NOT-AG-23-037: Notice of Special Interest (NOSI): Investigation of Biomolecular Condensates in Aging and Alzheimer's Disease (AD) and AD-related Dementias (ADRD)
NOT-AG-23-047: Notice of Participation of the National Institute on Aging (NIA) in PAR-23-219, "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)"
NOT-AG-23-048: Notice of Participation of the National Institute on Aging (NIA) in PAR-23-220, "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)"
NOT-AG-23-044: Notice of Intent to Publish a Funding Opportunity Announcement for High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Optional)
Comments